Codelivery of Phytochemicals with Conventional Anticancer Drugs in Form of Nanocarriers
Anticancer drugs in monotherapy are ineffective to treat various kinds of cancer due to the heterogeneous nature of cancer. Moreover, available anticancer drugs possessed various hurdles, such as drug resistance, insensitivity of cancer cells to drugs, adverse effects and patient inconveniences. Hen...
Saved in:
Main Authors: | Girish Kumar (Author), Tarun Virmani (Author), Ashwani Sharma (Author), Kamla Pathak (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Progress in Nanocarriers Codelivery System to Enhance the Anticancer Effect of Photodynamic Therapy
by: Yu-Ling Yang, et al.
Published: (2021) -
Nanocarriers in Tuberculosis Treatment: Challenges and Delivery Strategies
by: Mahesh Kumar, et al.
Published: (2023) -
Docetaxel and Doxorubicin Codelivery by Nanocarriers for Synergistic Treatment of Prostate Cancer
by: Ke Li, et al.
Published: (2019) -
Central Composite Design Implemented Azilsartan Medoxomil Loaded Nanoemulsion to Improve Its Aqueous Solubility and Intestinal Permeability: In Vitro and Ex Vivo Evaluation
by: Girish Kumar, et al.
Published: (2022) -
Multilayer Nanocarrier for the Codelivery of Interferons: A Promising Strategy for Biocompatible and Long-Acting Antiviral Treatment
by: Thelvia I. Ramos, et al.
Published: (2024)